Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

What Are Muscle Proteins Doing in the Nucleus?

No. 06 | 01/02/2005 | by (JL/JR)

The proteins actin and myosin have a firm place in the muscles where they are responsible for contraction. While recent investigations have shown that they are also found in the nucleus, it has been unclear to date just what they are doing there. Now an international team of investigators headed by Professor Dr. Ingrid Grummt, head of the Division of Molecular Biology of the Cell II of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), has shown that the muscle proteins in the nucleus are actively involved in transcription, i.e. the reading of genetic information.

“This is a breakthrough in molecular biology that revolutionizes our thinking about the transcription process,” said Ingrid Grummt. Jointly with investigators from Chicago, Prague, and Heidelberg, the scientist recently published an article in Nature Cell Biology* which has shattered a biological dogma that restricted the physiological role of the proteins actin and myosin to muscle contraction and their function as intracellular supporting elements.

The results are of fundamental relevance for cancer research, since the reading of genetic information and its translation into the cellular protein machine are essential for cell growth. In cancer cells, transcription activity is abnormally high, the cells are dividing uninhibited. “Once we learn to understand how this process is regulated in a normal cell, we will be able to investigate specifically what is going wrong in tumor cells and on this basis identify targets for therapeutic approaches,” Grummt explained.

While researchers had experimentally proven the presence of actin and myosin in nuclei before, a gene-regulatory function of these molecules has been fiercely debated. Grummt’s team has now been able to show that actin and myosin play an active role in the reading of genetic information called transcription. Using antibodies directed specifically against these proteins, the investigators blocked the transcription of genes that are needed for the production of ribosomes – the cellular protein synthesis devices. The antibody-induced blockage of transcription was reversed by adding the proteins. “The results suggest that the muscle proteins are associated directly with the key enzyme of transcription, RNA polymerase, and serve as a motor providing the energy required for RNA polymerase to dock to the right site and read the gene sequences.” Grummt favors the hypothesis that a complex of myosin and an essential transcription factor binds to RNA polymerase and thus causes a structural change in the polymerase. Actin seems to influence both the start and the further process of transcription. Altogether, actin and myosin appear to be central switching elements of transcription in the nucleus.

*“Nuclear actin and myosin I are required for RNA polymerase I transcription”. Nature Cell Biology, Vol. 6 / Number 12 / December 2004, pp. 1165 – 1172 / Vlada V. Philimonenko, Jian Zhao, Sebastian Iben, Hana Dingová, Katarina Kyselá, Michal Kahle, Hanswalter Zentgraf, Wilma A. Hofmann, Primal de Lanerolle, Pavel Hozák and Ingrid Grummt.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS